T1	HMM 663 767	European Organisation for Research and Treatment of Cancer Quality of Life (EORTC QOL)-C30 questionnaire
T2	HMM 843 936	(pain, anorexia, diarrhoea, fatigue, nausea and vomiting, dyspnea, constipation and insomnia)
T3	HMM 1142 1168	median time to progression
T4	HMM 1343 1358	median survival
T5	HMM 1583 1591	efficacy
T6	HMM 1596 1604	survival
T7	HMM 1654 1678	haematological toxicity.
T8	HMM 1679 1706	Non-haematological toxicity
